{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:17:50Z","timestamp":1762521470359},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T00:00:00Z","timestamp":1322006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10552-011-9877-6","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T05:41:25Z","timestamp":1321940485000},"page":"281-288","source":"Crossref","is-referenced-by-count":29,"title":["The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions"],"prefix":"10.1007","volume":"23","author":[{"name":"The HPV-IMPACT Working Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hariri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen C.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,23]]},"reference":[{"issue":"10 Suppl","key":"9877_CR1","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1002\/cncr.23756","volume":"113","author":"M Watson","year":"2008","unstructured":"Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, Schwenn M, Huang Y, Giuliano A (2008) Burden of cervical cancer in the United States, 1998\u20132003. Cancer 113(10 Suppl):2855\u20132864","journal-title":"Cancer"},{"issue":"4","key":"9877_CR2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55(4):244\u2013265","journal-title":"J Clin Pathol"},{"key":"9877_CR3","unstructured":"Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (2007) Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56(RR-2):1\u201324"},{"key":"9877_CR4","unstructured":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP) (2010). MMWR 59(20):626\u2013629"},{"issue":"10","key":"9877_CR5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","volume":"2","author":"SK Kjaer","year":"2009","unstructured":"Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G et al (2009) A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions. Cancer Prev Res (Phila) 2(10):868\u2013878","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9686","key":"9877_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","volume":"374","author":"J Paavonen","year":"2009","unstructured":"Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D et al (2009) Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 374(9686):301\u2013314","journal-title":"Lancet"},{"issue":"10 Suppl","key":"9877_CR7","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/cncr.23758","volume":"113","author":"M Watson","year":"2008","unstructured":"Watson M, Saraiya M, Ahmed F, Cardinez CJ, Reichman ME, Weir HK, Richards TB (2008) Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods. Cancer 113(10 Suppl):2841\u20132854","journal-title":"Cancer"},{"issue":"9590","key":"9877_CR8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370(9590):890\u2013907","journal-title":"Lancet"},{"issue":"19","key":"9877_CR9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"FUTURE The II","year":"2007","unstructured":"The FUTURE II, Group Study (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356(19):1915\u20131927","journal-title":"N Engl J Med"},{"issue":"3","key":"9877_CR10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/her\/cym021","volume":"23","author":"R Mullins","year":"2008","unstructured":"Mullins R, Wakefield M, Broun K (2008) Encouraging the right women to attend for cervical cancer screening: results from a targeted television campaign in Victoria, Australia. Health Educ Res 23(3):477\u2013486","journal-title":"Health Educ Res"},{"issue":"4","key":"9877_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1071\/NB01030","volume":"12","author":"S Macansh","year":"2001","unstructured":"Macansh S (2001) The role of the New South Wales Pap test register in monitoring the cervical screening process in New South Wales. N S W Public Health Bull 12(4):99\u2013102","journal-title":"N S W Public Health Bull"},{"issue":"1","key":"9877_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3201\/eid0701.010114","volume":"7","author":"A Schuchat","year":"2001","unstructured":"Schuchat A, Hilger T, Zell E, Farley MM, Reingold A, Harrison L, Lefkowitz L, Danila R, Stefonek K, Barrett N, Morse D, Pinner R (2001) Active bacterial core surveillance of the emerging infections program network. Emerg Infect Dis 7(1):92\u201399","journal-title":"Emerg Infect Dis"},{"key":"9877_CR13","unstructured":"National vaccination coverage among adolescents aged 13-17\u00a0years\u2013United States, 2006 (2007) MMWR 56(34):885\u2013888"},{"key":"9877_CR14","unstructured":"National, state, and local area vaccination coverage among adolescents aged 13\u201317\u00a0years\u2013United States, 2008 (2009) MMWR 58(36):997\u20131001"},{"key":"9877_CR15","unstructured":"National and state vaccination coverage among adolescents aged 13 through 17\u00a0years\u2013United States, 2010 (2011) MMWR 60(33):1117\u20131123"},{"issue":"3","key":"9877_CR16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121(3):621\u2013632","journal-title":"Int J Cancer"},{"issue":"4","key":"9877_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1158\/1055-9965.EPI-07-2629","volume":"17","author":"GH Rauscher","year":"2008","unstructured":"Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(4):748\u2013757","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9877_CR18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/epirev\/mxj006","volume":"28","author":"EJ Dasbach","year":"2006","unstructured":"Dasbach EJ, Elbasha EH, Insinga RP (2006) Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev 28:88\u2013100","journal-title":"Epidemiol Rev"},{"issue":"1","key":"9877_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3201\/eid1301.060438","volume":"13","author":"EH Elbasha","year":"2007","unstructured":"Elbasha EH, Dasbach EJ, Insinga RP (2007) Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 13(1):28\u201341","journal-title":"Emerg Infect Dis"},{"key":"9877_CR20","doi-asserted-by":"crossref","unstructured":"Garnett GP, Kim JJ, French K, Goldie SJ (2006) Chapter 21: modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24(Suppl 3):S178\u2013S186","DOI":"10.1016\/j.vaccine.2006.05.116"},{"issue":"1","key":"9877_CR21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajog.2004.01.043","volume":"191","author":"RP Insinga","year":"2004","unstructured":"Insinga RP, Glass AG, Rush BB (2004) Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 191(1):105\u2013113","journal-title":"Am J Obstet Gynecol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-011-9877-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9877-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T22:50:08Z","timestamp":1560984608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-011-9877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9877"],"URL":"https:\/\/doi.org\/10.1007\/s10552-011-9877-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2011,11,23]]}}}